NEW YORK (GenomeWeb News) – Illumina reported after the close of the market Monday that its first-quarter revenues increased 21 percent year over year as the firm swung to a loss due to litigation-related charges.

The San Diego-based firm posted revenues of $331 million for the three months ended March 31, compared to $272.8 million for the first quarter of 2012. It beat the average analyst estimate of $310.7 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.